Plato Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-47
Closed -$915 520
2025
Q2
$915 Sell
47
-1,366
-97% -$24.3K ﹤0.01% 512
2025
Q1
$25.4K Sell
1,413
-3,977
-74% -$85.7K ﹤0.01% 474
2024
Q4
$116K Buy
5,390
+1,370
+34% +$33.3K 0.01% 450
2024
Q3
$125K Buy
4,020
+43
+1% +$1.07K 0.01% 412
2024
Q2
$61.8K Buy
+3,977
New +$48.1K 0.01% 391

Other funds holding CDNA

Plato Investment Management's CDNA Position: Q3 2025 in Review

Plato Investment Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 47 shares — an estimated $915 sold.

Plato Investment Management first reported a position in CDNA in Q2 2024 and held it in 5 quarters. The position peaked at $125K in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Plato Investment Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Plato Investment Management sold 47 CareDx shares in Q3 2025, an estimated $915.
  • Plato Investment Management first reported a position in CareDx in Q2 2024 and held it in 5 quarters.
  • Plato Investment Management's CareDx position peaked at $125K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Plato Investment Management's 13F filing for Q3 2025, filed 5 Nov 2025.